A case of thoracic air leak syndrome with pleural parenchymal fibroelastosis after treatment for hematologic malignancy while awaiting lung transplantation: Imaging and pathological findings of rapid loss in lung volume.
Respir Med Case Rep
; 37: 101630, 2022.
Article
em En
| MEDLINE
| ID: mdl-35313561
We report the case of a 29-year-old man who underwent umbilical cord blood transplantation for chronic myelogenous leukemia 14 years previously. He was diagnosed with secondary pleuroparenchymal fibroelastosis (sPPFE) following treatment for hematologic malignancies (sPPFE after HM-Tx) 2.5 years ago. On computed tomography, pleural thickening in the upper lobe, lung volume loss, and recurrent bilateral pneumothorax were detected. Although he waited for cadaveric lung transplantation (LTx) for 1.5 years, his respiratory failure worsened, and he died. Pathological autopsy and clinical course indicated sPPFE. After diagnosing sPPFE after HM-Tx, the timing for deciding LTx is critical, especially when pneumothorax recurs.
BMT, bone marrow transplantation; BO, bronchiolitis obliterans; CT, computed tomography; GVHD, graft-versus-host disease; Hematopoietic stem cell transplantation; LONIPC, late-onset noninfectious pulmonary complication; LTx, lung transplantation; Lung transplantation; Pleuroparenchymal fibroelastosis; Pneumothorax; TALS, thoracic air-leak syndrome; Thoracic air-leak syndrome; UCBT, umbilical cord blood transplantation; VC, vital capacity; mMRC, modified Medical Research Council; sPPFE after HM-Tx, secondary pleuroparenchymal fibroelastosis following treatment for hematologic malignancies; sPPFE, secondary pleuroparenchymal fibroelastosis
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article